Another trial evaluating CSF1R inhibition in association with nivolumab was conducted, but shares no results [74], and a clinical trial evaluating a small molecule PLX3397 inhibiting CSF1R failed to show activity on GBM [75]. This evidence concerns the gene CSF1R and glioblastoma.